Barbosa Joana, Magalhães Rui, Santos Isabel, Ferreira Vânia, Brandão Teresa R S, Silva Joana, Almeida Gonçalo, Teixeira Paula
CBQF-Centro de Biotecnologia e Química Fina, Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa/Porto , Porto, Portugal .
Foodborne Pathog Dis. 2013 Oct;10(10):861-6. doi: 10.1089/fpd.2013.1532. Epub 2013 Aug 2.
The aim of this study was to characterize a broad collection of isolates of Listeria monocytogenes, of different serotypes, recovered in Portugal between 2003 and 2007 from foods (n=353) and from clinical cases of human listeriosis (n=95), in terms of antimicrobial susceptibility. All the isolates were susceptible to ampicillin, the preferred agent to treat listeriosis. Resistances to nitrofurantoin (n=99), to ciprofloxacin (n=18), to erythromycin (n=10), to tetracycline (n=2), to gentamicin (n=1) and to rifampicin (n=1) were observed. One hundred (28.3%) and 20 (21.0%) food and clinical isolates, respectively, were resistant to at least one antibiotic. Eight isolates (1.8%) were resistant to two or more antimicrobials of different classes, and all were collected from foods. Serogroup IVb included the highest percentage of isolates resistant to erythromycin. The highest percentages of isolates resistant to nitrofurantoin were of serogroup IVb and IIc. It was demonstrated that the incidence of antibiotic-resistant isolates of L. monocytogenes, during the period 2003 to 2007, was low in Portugal but still higher than that observed in other countries. Given the increasing population at greater risk of listeriosis, namely, the elderly, the high mortality rate of the infection and the detection of resistant isolates, monitoring for antibiotic resistance in strains of L. monocytogenes on a large scale, and assessing the risk of infection by these strains, is highly recommended.
本研究旨在对2003年至2007年期间在葡萄牙从食品(n = 353)和人类李斯特菌病临床病例(n = 95)中分离出的不同血清型的广泛单核细胞增生李斯特菌菌株进行抗菌药敏特性分析。所有分离株对氨苄西林敏感,氨苄西林是治疗李斯特菌病的首选药物。观察到对呋喃妥因(n = 99)、环丙沙星(n = 18)、红霉素(n = 10)、四环素(n = 2)、庆大霉素(n = 1)和利福平(n = 1)的耐药情况。分别有100株(28.3%)食品分离株和20株(21.0%)临床分离株对至少一种抗生素耐药。8株(1.8%)对两种或更多不同类别的抗菌药物耐药,且均从食品中分离得到。IVb血清群中对红霉素耐药的分离株比例最高。对呋喃妥因耐药的分离株中,IVb血清群和IIc血清群的比例最高。结果表明,2003年至2007年期间,葡萄牙单核细胞增生李斯特菌耐药分离株的发生率较低,但仍高于其他国家。鉴于李斯特菌病高危人群(即老年人)数量不断增加、该感染的高死亡率以及耐药分离株的检出情况,强烈建议对单核细胞增生李斯特菌菌株进行大规模抗生素耐药监测,并评估这些菌株的感染风险。